Democritus University of Thrace (DUTH)
Ο ανοσορυθμιστικός ρόλος της επιγενετικής θεραπείας στα μυελοδυσπλαστικά σύνδρομα (ΜΔΣ)
Abstract
dc:descriptionCD4+ T cells orchestrate immune responses and are actively engaged in shaping tumor immunity. Signal transducer and activator of transcription (STAT) signaling controls the epigenetic tuning of CD4+ T cell differentiation and polarization and perturbed STAT signaling networks in CD4+ T cells subvert antitumor immunity in malignancies. Azacitidine (AZA), the mainstay therapy for high-risk Myelodysplastic syndromes (HR-MDS), affects CD4+ T cell polarization and function, but whether this contributes to AZA efficacy is currently unknown. By employing functional proteomic, transcriptomic and mutational analyses in 73 HR-MDS patients undergoing AZA therapy, we demonstrate that responding patients exhibited a coordinated CD4+ T cell immune response and downregulated the inflammatory cytokine signaling pathways in CD4+ T cells after AZA, in contrast to non-responders who upregulated the same pathways. We further observed an AZA-mediated downregulation of intereukin-6—induced STAT3 phosphorylation in CD4+FOXP3- conventional CD4+ T cells (Tcons) that correlated independently with better response and survival, whereas it was also not associated with the mutation number and profile of the patients. The AZA-induced downregulation of IL-6/STAT3 axis in Tcons restored the STAT signaling architecture in CD4+ T cell subsets, while STAT signaling networks remained disorganized in patients who upregulated IL-6/STAT3 activity in Tcons. Given the pivotal role of CD4+ T cells in adaptive immunity, our findings suggest that the downregulation of IL-6/STAT3 pathway in Tcons potentially constitutes a previously unrecognized immune-mediated mechanism of action of AZA and set the scene for developing rational strategies of AZA combinations with IL-6/STAT3 axis inhibitors.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lamprianidou, Eleftheria
- Λαμπριανίδου, Ελευθερία
Subjects
dc:subject × 18- Σηματοδότηση STAT
- CD4 Τ λεμφοκύτταρα
- Υπομεθυλιωτικοί παράγοντες 5azacytidine 5AZADC
- Μυελοδυσπλαστικά σύνδρομα (MDS)
- Stat signaling
- CD4+ T lymphocytes
- Hypomethylating agents
- Myelodysplastic syndromes
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ανοσολογία
- Κλινική Ιατρική
- Αιματολογία
- Basic Medicine
- Medical and Health Sciences
- Immunology
- Clinical Medicine
- Hematology
Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48920